Document is current
Any future updates will be listed below
-
Authors
Van Obberghen, E. K.
Fabre, R.
Lanteri-Minet, M
- License Information
-
More Information
Article History
Received: 26 July 2025
Accepted: 18 August 2025
First Online: 4 December 2025
Declarations
:
: This systematic review did not require the authorization of an ethics committee.The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 07/22/2025 (registration number: CRD420251110095).
: Not applicable.
: EKVO had received personal fees for consultancy activities from Abbvie RF had no conflict of interest.MLM received personal fees for consultancy activities from: Abbvie/Allergan, Amgen, Eli Lilly, IPSEN, Lundbeck, Novartis, Orion Pharma, Perfood, Pfizer, Reckitt-Benckiser, Teva, UPSA..
